Skip to main content
Sister Publication Links
  • ModernHealthcare.com
Subscribe
  • My Account
  • Login
  • Register
  • Consumer Centric
  • Provider/Payer Centric
  • Funding/M&A
  • Policy
  • Data
  • Opinion
  • MORE+
    • Webinars
    • Advertise
MENU
Breadcrumb
  1. Home
  2. Finance
January 18, 2023 09:41 AM

Teladoc Health laying off 300 employees

Gabriel Perna
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    teladocphoto

    Teladoc Health is laying off 300 employees or 6% of its workforce, CEO Jason Gorevic said in an email to employees Wednesday.

    Gorevic said the telehealth company is eliminating redundant non-clinical roles that resulted from its $18.5 billion acquisition of digital health company Livongo Health in 2020. He also said the company is pushing towards a path to profitability. 

    “These actions put us on an even stronger financial footing at a time when many of our competitors are questioning their ability to keep their doors open,” Gorevic said in the email. 

    The layoffs follow a challenging 2022 for the company. It recorded a $9.8 billion net loss for the first three quarters of the year, largely because of a $9.6 billion goodwill impairment charge related to the Livongo merger. Its stock price has sunk from its high of $296.66 a share in February 2021 to $28.22 a share at Tuesday's close. 

    The Livongo acquisition hasn't gone according to plan for Teladoc. Along with the impairment charges, Livongo also lost Cigna as its preferred digital health tool for chronic care conditions in December 2021. 

    "They overpaid," said Nathan Ray, a partner in consultancy West Monroe’s healthcare and life sciences practice. "Look at some of the brick-and-mortar acquisitions we're seeing now with groups doing full primary care, including diabetes management, such as One Medical. [Companies like that] have a real asset, not just a call center with a digital presence, and they're going for much less than half of [what Livongo was sold for]." 

    At last week’s J.P. Morgan Healthcare Conference, Gorevic said Teladoc has $900 million on its balance sheet and positive cash flow and that the goodwill impairment charge doesn’t impact cash or liquidity. He also referenced what he said was the company's competitive advantage over rival telehealth providers to weather economic headwinds.

    “Many of the small competitors out there, whether they’re public or private, lack the scale to deliver strong financial results consistently,” Gorevic said. “There are a lot of virtual care companies out there that are more narrowly focused, smaller in scale and are nipping at the edges of single [software] solutions.

    Prateesh Maheshwari, investor at San Francisco-based Maverick Ventures, said he wasn't surprised that Teladoc had to cut jobs. He said the company is a bellwether for the digital health industry, which has come back down to Earth after investments peaked in 2021. 

    "A lot of these firms hired really quickly in 2020 and 2021. They looked at pandemic trends and thought that's how the world would look like for some period of time," Maheshwari said. "So the rationale for these layoffs is it's about rightsizing the organization. I wouldn't be surprised to see more happen."

    Teladoc's challenges are representative of the reality facing other tech-enabled service providers, said Dr. Justin Norden, partner at venture capital firm GSR Ventures. 

    “There have been a lot of layoffs [among] tech-enabled service companies and that will likely continue in 2023,” Norden said. “These companies were growing at low margin or in some cases, even negative gross margin. All of a sudden that is not exciting as an investor.”

    Teladoc’s 2022 revenue was approximately $2.4 billion, $1 billion of which came from BetterHelp, its direct-to-consumer mental health service.   

    Brock E.W. Turner contributed to the reporting of this article

    Related Article
    Teladoc CEO on potential M&A, cost cutting and more
    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it online.

    Recommended for You
    Alyssa Jaffee
    Five Questions: 7wireVentures’ Alyssa Jaffee
    money2_i_i.png
    GeneDx to raise $150M in public and direct stock offerings
    Sponsored Content
    Get Newsletters

    Newsletters for providers, payers, investors and innovators across the digital health ecosystem. Sign up to get breaking digital health news including digital health deals, M&A, finance, IPOs. as they happen, right to your inbox.

    Buy Q3 Report Today
    Quarterly Report Cover Image

    The Digital Health Funding and M&A Q3 report delivers the most comprehensive insight and data around the financial health of the sector.

    Purchase Today
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Digital Health Business & Technology delivers news, data, insights and analysis covering the entire digital healthcare ecosystem.

    Logo
    Contact Us

    (877) 812-1581

    Email us

     

    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    Resources
    • About Us
    • Contact Us
    • Staff
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Digital Health Business & Technology
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • Consumer Centric
    • Provider/Payer Centric
    • Funding/M&A
    • Policy
    • Data
    • Opinion
    • MORE+
      • Webinars
      • Advertise